Search research articles
Contact Us
Filters
Showing results (401-410 of 425) with videos related to
Page
of 43
Sort By:
BMJ Open
|
June 21, 2022
Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP)
Martin Risch, Kirsten Grossmann, Stefanie Aeschbacher, et al.
Journal of Veterinary Internal Medicine
|
December 7, 2018
Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018)
Joy E Tomlinson, Amit Kapoor, Arvind Kumar, et al.
Head & Neck
|
October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Stefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Plos One
|
March 6, 2024
Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study)
Kirsten Grossmann, Martin Risch, Andjela Markovic, et al.
Gastroenterology
|
November 11, 2021
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode, Hannah S J Choi, Chien-Hung Chen, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
Hannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 425) with videos related to
Sort By:
Page
of 43
BMJ Open
|
June 21, 2022
Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP)
Martin Risch, Kirsten Grossmann, Stefanie Aeschbacher, et al.
Journal of Veterinary Internal Medicine
|
December 7, 2018
Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018)
Joy E Tomlinson, Amit Kapoor, Arvind Kumar, et al.
Head & Neck
|
October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Stefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Journal of Hepatology
|
January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Plos One
|
March 6, 2024
Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study)
Kirsten Grossmann, Martin Risch, Andjela Markovic, et al.
Gastroenterology
|
November 11, 2021
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode, Hannah S J Choi, Chien-Hung Chen, et al.
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
Hannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
Page
of 43